Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer

NCT01772979 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype

Interventions

DRUG: Trabectedin

Sponsor

Catholic University of the Sacred Heart